Blog
RSS FeedPosted by Michael Wonder on 23 Jan 2018
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries
23 January 2018 - Although health technology assessment systems base their decision making process either on economic evaluations or comparative clinical ...
Posted by Michael Wonder on 20 Oct 2017
New action plan to foster development of advanced therapies
20 October 2017 - Actions address specific challenges identified by stakeholders. ...
Posted by Michael Wonder on 04 Oct 2017
Countdown to launch of new EudraVigilance system
4 October 2017 - Final preparations for change-over to new system underway for go live date on 22 November 2017 ...
Posted by Michael Wonder on 30 Jun 2016
Strengthening interaction with academia
30 June 2016 - EMA consults academia in preparation of a framework of collaboration. ...
Posted by Michael Wonder on 11 May 2016
Supporting innovative SMEs as major drivers of new pharmaceutical developments
12 May 2016 - EMA publishes report on the first ten years of its SME initiative. ...
Posted by Michael Wonder on 28 Apr 2016
Involving general practitioners in regulatory decisions on medicines
28 April 2016 - EMA workshop with general practitioners and family doctors kicks off strengthened collaboration. ...